Publications by authors named "Danielle M Thompson"
Background: Since 2022, the Commission on Cancer (CoC) has developed three new breast cancer quality measures (QMs): time to surgery (BCSdx) and radiation (BCSRT) and the use of neoadjuvant therapy for triple negative and HER2/neu positive breast cancer (BneoCT). This study assesses CoC center historical performance for these measures and facility factors associated with low performance.
Methods: We examined the median number of days for time to surgery and radiation, and the proportion of facilities that achieved an estimated performance rate (EPR) of 70%, 80%, and 90% from 2004 to 2020 for all three measures.
Article Synopsis
- - The National Accreditation Program for Breast Centers (NAPBC) initiated a quality collaborative to evaluate the time between breast cancer screening and treatment, analyzing data from 2019 to 2021.
- - A total of 373 accredited centers participated, with 311 providing complete metrics, revealing that the actual treatment time exceeded expectations across various intervals, from screening to diagnosis and biopsy to treatment.
- - Findings indicated discrepancies in treatment timing, with factors like higher case volumes and dedicated breast surgeons linked to longer intervals, highlighting the need for further investigation into quality measures across different centers.